{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:54:24Z","timestamp":1765886064419},"reference-count":73,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.neurol.2016.03.010","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T09:32:04Z","timestamp":1479375124000},"page":"779-784","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["What is new in 2015 in dysimmune neuropathies?"],"prefix":"10.1016","volume":"172","author":[{"given":"T.","family":"Kuntzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2016.03.010_bib0370","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1001\/jamaneurol.2015.2347","article-title":"The importance of rare subtypes in diagnosis and treatment of peripheral neuropathy: a review","volume":"72","author":"Callaghan","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0375","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s13311-015-0401-7","article-title":"Immunotherapy in peripheral neuropathies","volume":"13","author":"Leger","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurol.2016.03.010_bib0380","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00401-015-1466-4","article-title":"Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention","volume":"130","author":"Ubogu","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0385","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp-2014-310097","article-title":"Nodopathies of the peripheral nerve: an emerging concept","volume":"86","author":"Uncini","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.03.010_bib0390","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrneurol.2015.192","article-title":"Progress in inflammatory neuropathy - the legacy of Dr Jack Griffin","volume":"11","author":"Feldman","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0395","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000001833","article-title":"CIDP diagnostic pitfalls and perception of treatment benefit","volume":"85","author":"Allen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2016.03.010_bib0400","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/mus.24496","article-title":"Which criteria for research in chronic inflammatory demyelinating polyradiculoneuropathy? An analysis of current practice","volume":"51","author":"Rajabally","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.03.010_bib0405","first-page":"115","article-title":"Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"79","author":"FCIDPSG","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.03.010_bib0410","first-page":"1","article-title":"Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies","author":"Viala","year":"2015","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.neurol.2016.03.010_bib0415","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/jnnp-2014-308452","article-title":"Different electrophysiological profiles and treatment response in \u201ctypical\u201d and \u201catypical\u201d chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Kuwabara","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.03.010_bib0420","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp-2014-309697","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype","volume":"86","author":"Mathey","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.03.010_bib0425","doi-asserted-by":"crossref","first-page":"e0139689","DOI":"10.1371\/journal.pone.0139689","article-title":"Elevated vibration perception thresholds in cidp patients indicate more severe neuropathy and lower treatment response rates","volume":"10","author":"Abraham","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2016.03.010_bib0430","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/jns.12126","article-title":"Grip strength comparison in immune-mediated neuropathies: vigorimeter vs. jamar","volume":"20","author":"Draak","year":"2015","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2016.03.010_bib0435","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/mus.24707","article-title":"Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy","volume":"52","author":"Dyck","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.03.010_bib0440","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/jns.12127","article-title":"Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses","volume":"20","author":"Draak","year":"2015","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2016.03.010_bib0445","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/jns.12118","article-title":"Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison","volume":"20","author":"Vanhoutte","year":"2015","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2016.03.010_bib0450","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/jns5.12038","article-title":"Impairment and disability in 20 CIDP patients according to disease activity status","volume":"18","author":"Panaite","year":"2013","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2016.03.010_bib0455","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/ene.12767","article-title":"Disease status in chronic inflammatory demyelinating polyneuropathy: inter-centre comparative analysis and correlates","volume":"22","author":"Rajabally","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0460","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.clinph.2014.11.027","article-title":"Effects of low frequency filtering on distal compound muscle action potential duration for diagnosis of CIDP: a Japanese-European multicenter prospective study","volume":"126","author":"Mitsuma","year":"2015","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0465","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mus.24352","article-title":"Triple-stimulation technique improves the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"51","author":"Attarian","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.03.010_bib0470","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/mus.24693","article-title":"Diagnostic utility of somatosensory evoked potentials in chronic polyradiculopathy without electrodiagnostic signs of peripheral demyelination","volume":"53","author":"Devic","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.03.010_bib0475","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/WNL.0000000000001291","article-title":"Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity","volume":"84","author":"Di Pasquale","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2016.03.010_bib0480","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/jon.12079","article-title":"Correlation of nerve ultrasound, electrophysiological and clinical findings in chronic inflammatory demyelinating polyneuropathy","volume":"25","author":"Kerasnoudis","year":"2015","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.neurol.2016.03.010_bib0485","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.clinph.2015.01.011","article-title":"The ultrasound pattern sum score - UPSS. A new method to differentiate acute and subacute neuropathies using ultrasound of the peripheral nerves","volume":"126","author":"Grimm","year":"2015","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0490","article-title":"Axonal loss in patients with inflammatory demyelinating polyneuropathy as determined by motor unit number estimation and MUNIX","author":"Paramanathan","year":"2015","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0495","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/mus.24424","article-title":"Comparison of 2-limb versus 3-limb electrodiagnostic studies in the evaluation of chronic inflammatory demyelinating polyneuropathy","volume":"51","author":"Vo","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.03.010_bib0500","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.24314","article-title":"Reconstruction magnetic resonance neurography in chronic inflammatory demyelinating polyneuropathy","volume":"77","author":"Shibuya","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0505","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/mus.24978","article-title":"Frequent laboratory abnormalities in CIDP patients","volume":"53","author":"Abraham","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.03.010_bib0510","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10072-014-1935-x","article-title":"Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations","volume":"36","author":"Iorio","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neurol.2016.03.010_bib0515","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2015.03.023","article-title":"Circulating lymphocyte and T memory subsets in glucocorticosteroid versus IVIG treated patients with CIDP","volume":"283","author":"Klehmet","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0520","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jneuroim.2014.11.012","article-title":"Plasmacytosis is a common immune signature in patients with MMN and CIDP and responds to treatment with IVIg","volume":"278","author":"Korporal-Kuhnke","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0525","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2014.12.017","article-title":"Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyneuropathy","volume":"279","author":"Beppu","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0530","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneuroim.2015.07.012","article-title":"Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy","volume":"287","author":"Beppu","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0535","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.autrev.2014.08.005","article-title":"Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies","volume":"13","author":"Lim","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.neurol.2016.03.010_bib0540","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2015.05.017","volume":"285","author":"Blum","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0545","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/gene.2014.59","article-title":"Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"16","author":"Buttini","year":"2015","journal-title":"Genes Immun"},{"key":"10.1016\/j.neurol.2016.03.010_bib0550","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1212\/NXI.0000000000000148","article-title":"Deregulated Fcgamma receptor expression in patients with CIDP","volume":"2","author":"Quast","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.neurol.2016.03.010_bib0555","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jnnp-2014-309964","article-title":"Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy","volume":"87","author":"Wong","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.03.010_bib0560","first-page":"CD002062","article-title":"Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"1","author":"Hughes","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2016.03.010_bib0565","first-page":"CD003906","article-title":"Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"8","author":"Mehndiratta","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2016.03.010_bib0570","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jca.21384","article-title":"Long-term plasma exchange in pediatric CIDP","volume":"30","author":"Lucchetta","year":"2015","journal-title":"J Clin Apher"},{"key":"10.1016\/j.neurol.2016.03.010_bib0575","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nrneurol.2014.253","article-title":"Intravenous immunoglobulin in neurology\u2013mode of action and clinical efficacy","volume":"11","author":"Lunemann","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0580","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp-2014-309042","article-title":"Intravenous immunoglobulin response in treatment-naive chronic inflammatory demyelinating polyradiculoneuropathy","volume":"86","author":"Kuitwaard","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.03.010_bib0585","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jnnp-2013-307515","article-title":"Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP","volume":"86","author":"Nobile-Orazio","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.03.010_bib0590","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/mus.24743","article-title":"Maintenace therapy in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"52","author":"Latov","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.03.010_bib0595","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/mus.24554","article-title":"Long-term immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"51","author":"Rajabally","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.03.010_bib0600","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000350287","article-title":"Optimization of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy evaluated by grip strength measurement","volume":"70","author":"Kokubun","year":"2013","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0605","article-title":"Safety of IVIg in the elderly treated for a dysimmune neuromuscular disease","author":"Lozeron","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.03.010_bib0610","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mus.24526","article-title":"Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach","volume":"51","author":"Berger","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.03.010_bib0615","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12974-015-0361-1","article-title":"Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins","volume":"12","author":"Ritter","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurol.2016.03.010_bib0620","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/WCO.0000000000000233","article-title":"Paranodal and other autoantibodies in chronic inflammatory neuropathies","volume":"28","author":"Querol","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0625","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2016.03.010_bib0630","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0635","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies","volume":"86","author":"Doppler","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.03.010_bib0640","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1212\/NXI.0000000000000149","article-title":"Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins","volume":"2","author":"Querol","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.neurol.2016.03.010_bib0645","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/mus.24311","article-title":"Remission with fingolimod in a case of demyelinating polyneuropathy","volume":"50","author":"Erdener","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.03.010_bib0650","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000381767","article-title":"Natalizumab as a disease-modifying therapy in chronic inflammatory demyelinating polyneuropathy\u00a0\u2013\u00a0a report of three cases","volume":"73","author":"Vallat","year":"2015","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jns.12108","article-title":"CIDP-like neuropathies in graft versus host disease","volume":"20","author":"Cocito","year":"2015","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2016.03.010_bib0660","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/jnnp-2014-308586","article-title":"Polyneuropathy associated with duodenal infusion of levodopa in Parkinson's disease: features, pathogenesis and management","volume":"86","author":"Uncini","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.03.010_bib0665","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/practneurol-2014-001044","article-title":"99 years of Guillain\u2013Barre syndrome: pathophysiological insights from neurophysiology","volume":"15","author":"Uncini","year":"2015","journal-title":"Pract Neurol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0670","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/jnnp-2015-310601","article-title":"Early axonal Guillain\u2013Barre syndrome with normal peripheral conduction: imaging evidence for changes in proximal nerve segments","volume":"87","author":"Berciano","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.03.010_bib0675","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/ane.12459","article-title":"Hyponatraemia in Guillain\u2013Barre syndrome revisited","volume":"133","author":"Hiew","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2016.03.010_bib0680","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.24442","article-title":"Innate immunity to campylobacter jejuni in Guillain\u2013Barre syndrome","volume":"78","author":"Huizinga","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0685","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/jnnp-2014-309730","article-title":"Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy","volume":"86","author":"Antoine","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.03.010_bib0690","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s13311-015-0395-1","article-title":"Immunotherapy prospects for painful small-fiber sensory neuropathies and ganglionopathies","volume":"13","author":"Oaklander","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurol.2016.03.010_bib0695","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ajh.24171","article-title":"POEMS syndrome: update on diagnosis, risk-stratification, and management","volume":"90","author":"Dispenzieri","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.neurol.2016.03.010_bib0700","doi-asserted-by":"crossref","first-page":"450391","DOI":"10.1155\/2015\/450391","article-title":"Heterogeneity of polyneuropathy associated with anti-MAG antibodies","volume":"2015","author":"Magy","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.neurol.2016.03.010_bib0705","first-page":"CD005376","article-title":"Treatment for IgG and IgA paraproteinaemic neuropathy","volume":"3","author":"Stork","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2016.03.010_bib0710","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/mus.24652","article-title":"Sarcoid polyneuropathy masquerading as chronic inflammatory demyelinating polyneuropathy","volume":"52","author":"Singhal","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.03.010_bib0715","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/jns.12141","article-title":"Rasch-built overall disability scale for multifocal motor neuropathy (MMN-RODS((c)))","volume":"20","author":"Vanhoutte","year":"2015","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2016.03.010_bib0720","first-page":"CD003217","article-title":"Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy","volume":"3","author":"Umapathi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2016.03.010_bib0725","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/jnnp-2014-308118","article-title":"Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain\u2013Barre syndrome","volume":"86","author":"Cats","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.03.010_bib0730","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2015.08.008","article-title":"Non HCV-related infectious cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey and systematic review of the literature","volume":"65","author":"Terrier","year":"2015","journal-title":"J Autoimmun"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716302934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716302934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T12:50:03Z","timestamp":1536238203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378716302934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0035378716302934"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2016.03.010","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is new in 2015 in dysimmune neuropathies?","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2016.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}